Israeli scientist wins grant for very first COVID-19 cost-efficient design

Israeli scientist wins grant for very first COVID-19 cost-efficient design

on August 14, 2020

‘ We might state we are willing to do anything to stop the pandemic”, Dr. Ronen Arbel told ‘The Jerusalem Post,’ “however in reality, the general public does not imitate that.”

Ronen Arbel, Phd, Chair of the Technology Marketing Department Sapir Academic College (photo credit: SAPIR ACADEMIC COLLEGE PR ADVA ODAYA OGEN)

Ronen Arbel, Phd, Chair of the Technology Marketing Department Sapir Academic College

( image credit: SAPIR ACADEMIC COLLEGE PR ADVA ODAYA OGEN)

Ranging between NIS 50,000 to 100,000 per grant, the institute authorized 27 grants (including Arbel’s) out of 200 submissions, the institute representative informed the Post.

Arbel’s grant will fund the development of a brand-new information bank that will gather openly available information about how Israel and other countries have been attempting to curb the spread of COVID-19, as well as offer a prediction model to evaluate future actions.

Arbel went on to explain that public health policies generally take into account the quality-adjusted life year (QALY) aspect.

Read More
https://covid19globalcases.com/israeli-scientist-wins-grant-for-very-first-covid-19-cost-efficient-design/

Comments

Post a Comment

Popular Posts

Late-stage coronavirus vaccine trial starts today in the US

House News ( Image: © Shutterstock) While stage 1 and stage 2 trials examine dose, security, typical side results and effectiveness in a little number of individuals, the key to getting a vaccine authorized is the stage 3 trial, which evaluates for vaccine effectiveness while monitoring for adverse occasions in a much bigger group of people, according to a previous Live Science report Related: Coronavirus live updates Moderna’s vaccine uses an innovation that hasn’t yet been used in any approved vaccines to date, however has a number of benefits, consisting of being quicker and easier to produce than traditional vaccines, Live Science previously reported. Early results from a stage 1 trial consisting of 45 individuals suggested that the vaccine prompted an immune action and appeared safe and usually well-tolerated, according to findings published on July 14 in The New England Journal of Medicine Read More https://covid19globalcases.com/late-...

kauwa ud more ud gadha ud #comedy #newcomedy #newstatus #coronavirus #comedyshorts #ytshorts

https://covid19globalcases.com/kauwa-ud-more-ud-gadha-ud-comedy-newcomedy-newstatus-coronavirus-comedyshorts-ytshorts/

COVID-19 sign self-reporting app from startup Zoe and scholastic partners expands to the U.S.

If you wish to contribute to efforts to much better understand and consist of the COVID-19 pandemic, and you’re based in the U.S., you can do a lot with really little effort by downloading a complimentary iOS and Google Play application called simply COVID Sign Tracker. The app was originally established in partnership with food science start-up Zoe and launched first in the U.K.; it was quickly downloaded by nearly one million people in its first day of accessibility. The app intends to supplement details offered by screening programs and other public steps of the spread of the coronavirus using self-reported details supplied by individuals. It consists of a self-reporting test that takes roughly one minute daily to complete, and likewise offers a projected image of the prospective spread of the virus in your instant area. There are a number of various, similar efforts to utilize self-reported information as a signal in determining the full spread of the virus, i...

Powered by Blogger